| 000 -LEADER |
|---|
| fixed length control field |
04586nam a22004335i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20140310150643.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120503s2012 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781461433149 |
|
978-1-4614-3314-9 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC648-665.2 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.4 |
| Edition number |
23 |
| 264 #1 - |
|---|
| -- |
New York, NY : |
| -- |
Springer New York, |
| -- |
2012. |
| 912 ## - |
|---|
| -- |
ZDB-2-SME |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
LeRoith, Derek. |
| Relator term |
editor. |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Prevention of Type 2 Diabetes |
| Medium |
[electronic resource] : |
| Remainder of title |
From Science to Therapy / |
| Statement of responsibility, etc |
edited by Derek LeRoith. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XIII, 259 p. 49 illus., 32 illus. in color. |
| Other physical details |
online resource. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
01.Prevention of Type 2 Diabetes; from Science to Therapies: Introduction -- 02.Pathophysiology: Loss of ß-cell function -- 03.Pathophysiology of Insulin Resistance: Implications for Prevention -- 04.Epidemiology Including Youth through Adulthood & Socioeconomic Impact.- 05.Prediabetes Genes in Pima and Amish -- 06.Predicting Diabetes -- 07.Screening for Prediabetes and Diabetes -- 08.Neuropathy in pre-Diabetes and the Metabolic Syndrome -- 09.Interventional Trials to Prevent Diabetes: Diabetes Prevention Program.- 10.Decreasing Postprandial Plasma Glucose in Subjects with IGT by Using an α (alpha)-Glucosidase Inhibitor for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial.-11.Da Qing, Finnish DPP, Tripod and Dream: Lifestyle and Thiazolidinediones in the Prevention of Diabetes.- 12.Community Approaches to Diabetes Prevention -- 13.Think Locally, Act Locally, Extend Globally: Diabetes Prevention Through Partnerships with Local Communities.- 14.Global Challenge in Diabetes Prevention from Practice to Public Health. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
There is a world-wide epidemic on obesity. This epidemic is driving the immense proportions of Type 2 diabetes across the globe. While there are numerous therapies for treating Type 2 diabetes, the most effective therapy is prevention. Prevention of Type 2 diabetes can be achieved properly by simultaneous prevention of obesity. Prediabetes, or metabolic syndrome, is the period between simple obesity and diabetes, and this critical period needs to be identified in a more consistent and systematic manner by clinicians worldwide. Clinical trials have indicated that diabetes prevention can be achieved by lifestyle changes and also by certain medications, though none are yet approved for use in prevention. On the other hand, there are funding agencies such as the NIH, CDC, and State Institutions that are interested in studying the prevention paradigms in different communities and ethnic minorities who are most prone to this epidemic. For these reasons, this title by renowned physician-scientist Derek LeRoith is both timely and vitally important for academic physicians, practitioners, allied health care providers, analysts, community activists, and all others interested in this increasing epidemic. This book provides a unique and comprehensive synthesis of the prevention and early diagnosis of Type 2 Diabetes, focusing on identifying risk factors and then moving into topics that address how to prevent their progression to full-blown diabetes. The difficult task of changing patients’ behavior is given special emphasis. The chapters in this practical volume are written by a wide range of international experts, refelecting the editor’s distinguished, internationally renowned career. The volume is organized in eight sections: an introduction to the overall issue of prevention, definitions of values based on ADA guidelines, pathophysiology, discussion of a range of interventional trials regarding prevention, and an overview of state-of-the-art clinical management approaches. Comprehensive and timely, Prevention of Type 2 Diabetes: From Science to Therapy is an essential reference for those treating and researching Type 2 Diabetes. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine. |
|
|---|
| Topical term or geographic name as entry element |
Family medicine. |
|
|---|
| Topical term or geographic name as entry element |
Internal medicine. |
|
|---|
| Topical term or geographic name as entry element |
Endocrinology. |
|
|---|
| Topical term or geographic name as entry element |
Medicine & Public Health. |
|
|---|
| Topical term or geographic name as entry element |
Endocrinology. |
|
|---|
| Topical term or geographic name as entry element |
Internal Medicine. |
|
|---|
| Topical term or geographic name as entry element |
General Practice / Family Medicine. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Display text |
Printed edition: |
| International Standard Book Number |
9781461433132 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4614-3314-9 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
E-Book |
